GlassScriptPhysician profile
Patrick W Russell
NPI 1144205113
$975.64
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $391 · 2021: $14.26 · 2024: $15.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $183.04 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $170.69 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $82.91 | 2019-2020 | |
| Acorda Therapeutics, INC | $60.72 | 2019-2020 | |
| Genzyme Corporation | $54.87 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.06 | 2019-2020 | |
| Allergan, INC. | $44.79 | 2019-2020 | |
| Lundbeck LLC | $42.16 | 2020 | |
| Merz North America, INC. | $39.96 | 2020 | |
| Biogen, INC. | $32.76 | 2020 | |
| Abbvie INC. | $30.24 | 2019-2021 | |
| Lilly USA, LLC | $27.78 | 2020 | |
| Amneal Pharmaceuticals LLC | $27.51 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $22.22 | 2020 | |
| Medtronic USA, INC. | $21.67 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $18.70 | 2020 | |
| Saol Therapeutics INC. | $15.73 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.72 | 2019 | |
| Upsher-Smith Laboratories LLC | $13.97 | 2019 | |
| Ucb, INC. | $13.11 | 2019 | |
| Acadia Pharmaceuticals INC | $12.03 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.